Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets close in 6 hours 42 minutes
FTSE 100
8,427.90
+46.55
(+0.56%)
FTSE 250
20,617.76
+86.46
(+0.42%)
AIM
786.18
+2.48
(+0.32%)
GBP/EUR
1.1622
+0.0011
(+0.10%)
GBP/USD
1.2532
+0.0008
(+0.06%)
Bitcoin GBP
50,213.70
+1,232.08
(+2.52%)
PROPERTY
Homes with investment potential
These residential properties could bring in a good ROI
Ayala Pharmaceuticals, Inc. (ADXS)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5600
-0.0650
(-10.40%)
At close: 03:56PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
13
13
692
3,506
3,708
Cost of revenue
13
13
602
3,506
3,708
Gross profit
0
0
90
0
0
Operating expenses
Research development
24,081
24,081
27,851
29,941
22,406
Selling general and administrative
12,185
12,185
9,742
9,277
7,371
Total operating expenses
36,266
36,266
37,593
39,218
29,777
Operating income or loss
-36,266
-36,266
-37,503
-39,218
-29,777
Interest expense
15,746
15,746
0
260
-
Income before tax
-51,984
-51,984
-37,429
-39,478
-29,721
Income tax expense
-3,912
-3,912
584
776
425
Income from continuing operations
-48,072
-48,072
-38,013
-40,254
-30,146
Net income
-48,072
-48,072
-38,013
-40,254
-30,146
Net income available to common shareholders
-48,072
-48,072
-38,013
-40,254
-30,146
Basic EPS
-2.51
-7.99
-13.13
-2.80
-3.06
Diluted EPS
-2.51
-7.99
-13.13
-2.80
-3.06
Basic average shares
15,325
6,019
2,895
14,399
9,861
Diluted average shares
15,325
6,019
2,895
14,399
9,861
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.